Baloise stock gains as Helvetia Baloise posts strong half-year 2026 earnings

Published on 09/17/2026 at 12:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Baloise stock benefits from Helvetia Baloise underlying earnings of CHF 631.6 million in the first half of 2026 and a higher synergy target as of September 17, 2026. The group now plans to reach about 60 percent of its CHF 650 million synergy goal by the end of 2026 while keeping capitalisation robust.

Baloise Holding AG (CH0012410517) - Makro — Baloise Holding AG (CH0012410517) in extremer Makro-Nahaufnahme mit scharfen Details und schmalem Schärfebereich, Illustration mit AI erstellt.

Helvetia Baloise Holding AG, which includes Baloise stock (ISIN CH0012410517), is in the spotlight on September 17, 2026 after reporting strong underlying earnings of CHF 631.6 million for the first half of 2026 and raising its synergy guidance while maintaining a solid capital position. As EQS News reported on September 17, 2026, the newly merged group also delivered an annualised underlying return on adjusted equity of 18.7 percent for H1 2026, above its medium-term target range.

Half-year 2026 earnings and margins impress

According to EQS News, Helvetia Baloise generated underlying earnings of CHF 631.6 million in the first half of 2026, significantly higher than the comparable prior-year level of CHF 271.8 million, which means underlying profit more than doubled year on year. The group achieved an annualised underlying return on adjusted equity of 18.7 percent in H1 2026, compared with a target range of 16 to 18 percent for the years 2026 to 2028, indicating that profitability currently sits above the upper end of its own ambition.

The same release highlights a combined ratio of 92.0 percent for H1 2026, reflecting continued underwriting discipline in the non-life business and leaving ample room for technical profits. While IFRS net income came in at CHF 84.6 million in the first half of 2026, lower than the prior-year IFRS result due to a non-cash amortisation of CHF 671.7 million on merger-related intangible assets, underlying earnings in non-life alone amounted to CHF 399.4 million, underscoring that the operational trend remains robust despite accounting charges.

Synergy targets raised and integration ahead of plan

As EQS News notes, Helvetia Baloise is progressing with integration faster than initially planned and has already secured close to 50 percent of its long-term synergy run-rate target of CHF 650 million as of June 30, 2026. Reflecting this progress, management now expects to achieve around 60 percent of the CHF 650 million synergy target by the end of 2026, up from the previous expectation of around 50 percent for that date, while the long-term target itself remains unchanged.

The group also underscores its financial strength, with an estimated Swiss Solvency Test (SST) ratio of around 270 percent as of June 30, 2026, according to the same disclosure, comfortably above regulatory requirements and underpinned by an A plus financial strength rating from S and P. For investors watching Baloise stock within the broader Helvetia Baloise group, this combination of rising synergies, strong operating profitability and high capitalisation suggests that the merger is already delivering tangible financial benefits relative to the pre-merger baseline.

Analyst views and stock performance signal upside and risks

Market reaction has been constructive: according to Zonebourse, Helvetia Baloise registered shares were up about 3.4 percent to CHF 221.00 in early trading on September 17, 2026, outperforming the SLI index, which rose by about 0.44 percent at the same time. In the same report, Zürcher Kantonalbank maintains its recommendation at Overweight with a fair value estimate of CHF 245.00 per share, while Vontobel keeps a Hold rating and a price target of CHF 230.00, illustrating that some analysts see additional upside from the current price level whereas others highlight a more balanced risk-reward profile.

The H1 2026 results also show that Helvetia Baloise is growing its life and non-life business volumes, with life business volume reaching CHF 4,605.9 million in the first half of 2026 and total equity standing at CHF 13.0 billion as of June 30, 2026, as detailed by EQS News. For Baloise-focused investors, a key risk flagged by several outlets is that the IFRS net income of CHF 84.6 million in H1 2026 is substantially lower than the prior-year IFRS profit of CHF 320.1 million because of the accelerated amortisation of CHF 671.7 million in merger-related intangible assets, as highlighted by finanzen.ch, although this charge does not affect the group’s dividend capacity.

Baloise stock in the Helvetia Baloise context

On the equity market, Helvetia Baloise registered shares, which now incorporate the former standalone Baloise stock, traded around CHF 221.00 on SIX Swiss Exchange during the morning session of September 17, 2026, compared with analyst fair value estimates of CHF 230.00 and CHF 245.00 from Vontobel and Zürcher Kantonalbank respectively, indicating that the stock is currently changing hands at a single-digit discount to the higher of these targets. With a combined business volume of about CHF 11.7 billion and shareholder equity of around CHF 13.0 billion as of June 30, 2026, as reported by Tages-Anzeiger, investors are effectively paying a modest premium over book value for a group that has already delivered an 18.7 percent underlying return on adjusted equity in its first reported half-year.